Cytek Biosciences (CTKB) Research & Development (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Research & Development came in at $9.6 million in Q1 2026, down 1.24% YoY from $9.7 million in Q1 2025, and down 26.86% on a QoQ basis from $13.1 million in Q4 2025.
Cytek Biosciences (CTKB) Research & Development (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Research & Development data on file, last reported at $9.6 million in Q1 2026.
- Quarterly Research & Development fell 1.24% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.5 million (up 3.02% YoY) and the FY2025 annual result came in at $49.4 million, up 25.48% from the prior year.
- Research & Development fell to $9.6 million in Q1 2026, from $13.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $13.1 million in Q4 2025 to a low of $7.0 million in Q1 2022.
- A 5-year average of $10.1 million and a median of $9.7 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development surged 60.13% — and 2025, when it decreased 22.47%.
- Tracing CTKB's Research & Development over 5 years: stood at $9.7 million in 2022, then advanced by 18.61% to $11.6 million in 2023, then fell by 15.9% to $9.7 million in 2024, then surged by 35.05% to $13.1 million in 2025, then dropped by 26.86% to $9.6 million in 2026.
- The last three Research & Development figures came in at $9.6 million (Q1 2026), $13.1 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Cytek Biosciences | 605.23 Mn | 531.38 Mn | 28.34 Mn | 13.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.17 Mn |
| Mar 31, 2026 | 9.60 Mn |
| Dec 31, 2025 | 13.13 Mn |
| Sep 30, 2025 | 8.96 Mn |
| Jun 30, 2025 | 8.83 Mn |
| Mar 31, 2025 | 9.73 Mn |
| Dec 31, 2024 | 9.72 Mn |
| Sep 30, 2024 | 9.88 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 12.54 Mn |
| Dec 31, 2023 | 11.56 Mn |
| Sep 30, 2023 | 11.17 Mn |
| Jun 30, 2023 | 12.14 Mn |
| Mar 31, 2023 | 11.15 Mn |
| Dec 31, 2022 | 9.75 Mn |
| Sep 30, 2022 | 8.65 Mn |
| Jun 30, 2022 | 8.44 Mn |
| Mar 31, 2022 | 6.96 Mn |
| Dec 31, 2021 | 8.04 Mn |
| Sep 30, 2021 | 6.08 Mn |